The global sphygmomanometer market size accounted for US$ 2.2 billion in 2021 and is projected to reach around USD 4.8 billion by 2030, growing at a CAGR of 9.06% from 2022 to 2030. The rising number of persons suffering from blood-related diseases such as hypertension has boosted market growth.
Sphygmomanometer Market Key Takeaways:
- By product, the electronic sphygmomanometer segment held highest share of over 37.6% in 2021.
- By operations, manual segment held highest market share of over 33.6% in 2021.
- By configuration, the portable segment has accounted 29.8% in the year 2021.
- By end-user, hospitals segment has contributed 31.9% of market share 2021.
- North America region has captured a major revenue share of 34.2% in 2021.
Report Summary
The global sphygmomanometer market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the sphygmomanometer market across the globe.
A comprehensive estimate on the sphygmomanometer market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of sphygmomanometer during the forecast period. Price point comparison by region with global average price is also considered in the study.
Sphygmomanometer Market Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 2.4 Billion |
| Market Size by 2030 | USD 4.8 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.06% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Operation, Configuration, End User, and Geography |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized sphygmomanometer market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Hydrogen Fuel Cell Vehicle Market Size Analysis 2022 To 2030
Sphygmomanometer Market Players
The report includes the profiles of key sphygmomanometer market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area are A & D Company (India), Welch Allyn (U.S.), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Omron (Japan), Beurer GmbH (Germany), Paul Hartmann AG (Germany), Microlife Corporation (Switzerland), American Diagnostic (U.S.), Rossmax International (Japan), Rudolf Riester GmbH (Germany), Briggs Healthcare (U.S.), Terumo Corporation (Japan)
Market Segmentation
By Product
- Electronic Sphygmomanometer
- Aneroid Sphygmomanometer
- Mercury Sphygmomanometer
By Operation
- Electric
- Manual
- Automatic
- Semi-automatic
By Configuration
- Portable
- Desk Mounted
- Floor Standing
- Wall Mounted
By End-User
- Hospitals
- Ambulatory Surgical Centers & Clinics
- Home Healthcare
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sphygmomanometer Market
5.1. COVID-19 Landscape: Sphygmomanometer Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sphygmomanometer Market, By Product
8.1. Sphygmomanometer Market, by Product, 2022-2030
8.1.1. Electronic Sphygmomanometer
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Aneroid Sphygmomanometer
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Mercury Sphygmomanometer
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Sphygmomanometer Market, By Operation
9.1. Sphygmomanometer Market, by Operation, 2022-2030
9.1.1. Electric
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Manual
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Automatic
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Semi-automatic
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Sphygmomanometer Market, By Configuration
10.1. Sphygmomanometer Market, by Configuration, 2022-2030
10.1.1. Portable犀利士
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Desk Mounted
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Floor Standing
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Wall Mounted
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Sphygmomanometer Market, By End-User
11.1. Sphygmomanometer Market, by End-User, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Ambulatory Surgical Centers & Clinics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Home Healthcare
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Sphygmomanometer Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.4. Market Revenue and Forecast, by End-User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Operation (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Operation (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Configuration (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 13. Company Profiles
13.1. A & D Company (India)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Welch Allyn (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Koninklijke Philips N.V. (Netherlands)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. General Electric (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Omron (Japan)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Beurer GmbH (Germany)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Paul Hartmann AG (Germany)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Microlife Corporation (Switzerland)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. American Diagnostic (U.S.)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Rossmax International (Japan)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2233
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com